GENTILESCHI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 6.437
EU - Europa 5.071
AS - Asia 4.219
SA - Sud America 722
Continente sconosciuto - Info sul continente non disponibili 390
AF - Africa 252
OC - Oceania 10
Totale 17.101
Nazione #
US - Stati Uniti d'America 6.273
RU - Federazione Russa 1.443
IT - Italia 1.441
SG - Singapore 1.420
CN - Cina 1.052
VN - Vietnam 580
BR - Brasile 577
GB - Regno Unito 573
IE - Irlanda 410
HK - Hong Kong 305
DE - Germania 246
KR - Corea 237
FR - Francia 236
FI - Finlandia 189
BD - Bangladesh 182
IN - India 147
SE - Svezia 144
ZA - Sudafrica 123
UA - Ucraina 106
CA - Canada 81
NL - Olanda 71
PL - Polonia 55
JP - Giappone 47
AR - Argentina 45
MX - Messico 44
IQ - Iraq 36
TR - Turchia 33
CI - Costa d'Avorio 32
KE - Kenya 31
CZ - Repubblica Ceca 28
EC - Ecuador 27
ES - Italia 25
PK - Pakistan 22
AT - Austria 18
VE - Venezuela 18
ID - Indonesia 16
SA - Arabia Saudita 16
UZ - Uzbekistan 16
MA - Marocco 14
CL - Cile 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
IR - Iran 12
PY - Paraguay 12
DZ - Algeria 11
PH - Filippine 11
AU - Australia 10
BE - Belgio 10
JM - Giamaica 10
LT - Lituania 10
UY - Uruguay 10
CO - Colombia 9
CR - Costa Rica 9
JO - Giordania 9
MY - Malesia 9
EG - Egitto 8
NG - Nigeria 8
NP - Nepal 8
AL - Albania 7
LB - Libano 7
PE - Perù 7
TN - Tunisia 7
BY - Bielorussia 6
AM - Armenia 5
DK - Danimarca 5
HR - Croazia 5
IL - Israele 5
KZ - Kazakistan 5
DO - Repubblica Dominicana 4
RS - Serbia 4
TW - Taiwan 4
BH - Bahrain 3
GR - Grecia 3
HU - Ungheria 3
LV - Lettonia 3
NO - Norvegia 3
PA - Panama 3
SV - El Salvador 3
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
CG - Congo 2
CY - Cipro 2
ET - Etiopia 2
EU - Europa 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
LI - Liechtenstein 2
LY - Libia 2
MD - Moldavia 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
TG - Togo 2
Totale 16.688
Città #
Dallas 1.356
Singapore 911
Ashburn 454
Milan 428
Santa Clara 428
Southend 415
San Jose 409
Dublin 401
Moscow 398
Hefei 372
Council Bluffs 327
Hong Kong 282
Fairfield 243
Seoul 234
Beijing 211
Ho Chi Minh City 185
Rome 184
New York 170
Siena 160
Chandler 156
Hanoi 153
Los Angeles 153
Woodbridge 131
Lauterbourg 120
The Dalles 118
Johannesburg 113
Munich 110
Helsinki 109
Houston 104
Seattle 101
Cambridge 87
Jacksonville 81
Wilmington 79
Menlo Park 74
São Paulo 65
Columbus 59
Orem 59
Florence 56
Ann Arbor 53
Bengaluru 52
Buffalo 52
Chicago 47
Princeton 43
Dearborn 42
Lappeenranta 42
Warsaw 38
Chennai 37
Frankfurt am Main 37
Redondo Beach 36
London 33
Abidjan 32
Da Nang 31
Nanjing 29
Turin 29
Turku 29
Tokyo 28
Figino 26
Portsmouth 26
Montreal 25
Denver 23
Shanghai 23
Atlanta 22
Boardman 22
Naples 22
Amsterdam 21
Brooklyn 21
Haiphong 21
Düsseldorf 19
Manchester 19
San Mateo 19
Stockholm 19
Mexico City 18
Olomouc 18
San Francisco 18
Toronto 18
Baghdad 17
Nuremberg 17
Phoenix 17
San Diego 16
Tashkent 15
Belo Horizonte 14
Boston 14
Rio de Janeiro 14
Washington 14
Guayaquil 13
Campinas 12
Poplar 12
Charlotte 11
Hillsboro 11
Newark 11
Curitiba 10
Fortaleza 10
Guangzhou 10
Hải Dương 10
Mumbai 10
Nairobi 10
Piscataway 10
Salt Lake City 10
Vienna 10
Amman 9
Totale 10.893
Nome #
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 413
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 357
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 352
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 347
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 334
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 329
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 322
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 305
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 299
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 288
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 281
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 273
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 265
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 244
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 236
Doppler and Spectral Ultrasound of Sacroiliac Joints in Pediatric Patients with Suspected Juvenile Spondyloarthritis 234
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 232
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 231
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 230
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 225
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome 216
Inflammatory muscle involvement in systemic vasculitis: A systematic review 216
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 212
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 210
Development and implementation of the AIDA International Registry for patients with Behçet's disease 210
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 207
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 202
Baricitinib retention rate: ‘real-life’ data from a mono-centric cohort of patients affected by rheumatoid arthritis 199
Diagnostic accuracy of OGUS, Southend halo score and halo count in giant cell arteritis 195
Ultrasound guided corticosteroids sacroiliac joint injections (SIJIs) in the management of active sacroiliitis: a real-life prospective experience 194
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 193
A fluffy white retinal lesion in a woman with spondyloarthritis treated with tofacitinib 191
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 191
Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis – retrospective study 187
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 184
Intra-articular injections of biological disease-modifying anti-rheumatic drugs in inflammatory arthropathies: An up-to-date narrative review 181
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 181
The Role of Major Salivary Gland Ultrasound in the Diagnostic Workup of Sicca Syndrome: A Large Single-Centre Study 179
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 177
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 176
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry 172
Low muscle mass and body composition analysis in a group of postmenopausal women affected by primary Sjögren’s syndrome 168
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 161
The diagnostic role of pathergy test in patients with Behçet’s disease from the Western Europe 160
Clinical spectrum of small-vessel vasculitis related to cocaine consumption: data from an Italian cohort 160
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network 160
Diagnostic role of minor salivary glands biopsy in Sjögren’s syndrome: correlations between histology and autoimmunity in a large, monocentric cohort 156
Evolving Frontiers in the Treatment of Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Syndrome 156
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 155
Paraneoplastic arthritides: an up-to-date case-based systematic review 154
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 153
Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort 153
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 150
Polymyalgia Rheumatica: a syndrome with an enthesitic subset? Comment on: “Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice” by Marie Pean de Ponfilly–Sotier et al. Joint Bone Spine 2021;89:105325 150
Polymyalgia rheumatica following infective triggers or vaccinations: A different subset of disease? 149
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre study 149
Neridronate for transient osteoporosis of the hip in a child 145
Bone-sparing effects of tocilizumab in rheumatoid arthritis: a monocentric observational study 145
Development and implementation of the international AIDA network spondylarthritis registry 144
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 142
Clinical response to brodalumab in a patient affected by refractory SAPHO syndrome 142
Intravenous neridronate is effective in regional migratory osteoporosis 142
Efficacy of intravenous neridronate in transient osteoporosis of the hip 139
Power and spectral Doppler ultrasound in suspected active sacroiliitis: A comparison with magnetic resonance imaging as gold standard 137
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA network registries 136
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 134
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries 130
Effects of antiresorptive agents on body composition: a case-control retrospective study 129
Efficacy and safety of tocilizumab in adult-onset Still's disease: real-life experience from the international AIDA registry 128
Upadacitinib and ustekinumab combination treatment for a refractory case of spondyloarthritis and Crohn’s disease 127
The current status of biological treatment for uveitis 127
Difference in pain and accuracy of two hyaluronic acid injection techniques for symptomatic knee osteoarthritis in overweight patients 126
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: a multicenter study from the AIDA Network PFAPA syndrome registry 126
Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma 125
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 125
A Fixed Combination of Palmitoylethanolamide and Melatonin (PEATONIDE) for the Management of Pain, Sleep, and Disability in Patients with Fibromyalgia: a Pilot Study 122
Routine IgG4 staining in minor salivary gland biopsy in a cohort of Italian Caucasian patients suffering from xerostomia 116
Imaging findings in patients with axial spondyloarthritis presenting with recurrent fever attacks: data from the international AIDA network spondyloarthritis registry 113
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 111
Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement 107
The autoinflammatory diseases alliance registry of monogenic autoinflammatory diseases 100
The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases 100
Sézary syndrome during anti-IL17 treatment 100
Effectiveness of SB5, an adalimumab biosimilar, in patients with noninfectious uveitis: a real-life monocentric experience 98
Ultrasound description of cortical-entheseal bone remodeling in peripheral entheses of patients with psoriasis and nonspecific musculoskeletal symptoms 97
Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study 93
Switching from rituximab originator to GP2013 or CT-P10 biosimilars in autoimmune rheumatic diseases: drug retention rate and safety data from a multicentric retrospective cohort 91
Role of adalimumab biosimilar in the treatment of non-anterior uveitis associated with Behçet’s syndrome 90
Systemic auto-inflammatory manifestations in patients with spondyloarthritis 89
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 80
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry 73
Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis Registry 67
Clinical aspects of psoriatic arthritis: one year in review 2024 65
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 62
Axial spondyloarthritis: one year in review 2023 57
Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis Registry 54
The potential role of GLP-1 receptor agonists in the management of psoriatic disease: a scoping review 53
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 52
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib 50
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 49
Totale 16.842
Categoria #
all - tutte 49.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022339 0 0 25 22 13 9 22 22 24 40 64 98
2022/2023614 32 57 69 65 53 118 26 61 63 18 34 18
2023/2024836 17 15 72 48 32 215 242 42 10 13 29 101
2024/20253.077 151 132 393 106 329 174 144 167 233 155 285 808
2025/20269.474 564 1.185 1.113 1.129 1.588 341 1.088 328 405 500 412 821
2026/2027855 414 387 54 0 0 0 0 0 0 0 0 0
Totale 17.101